---
figid: PMC6291713__ajtr0010-3413-f8
figtitle: JAK2 overexpression alleviates C2C12 myoblasts I/R injury through the AKT
  and ERK1/2 pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6291713
filename: ajtr0010-3413-f8.jpg
figlink: /pmc/articles/PMC6291713/figure/fig08/
number: F8
caption: 'JAK2 overexpression alleviates C2C12 myoblasts I/R injury through the AKT
  and ERK1/2 pathway. As JAK2 is overexpressed in C2C12 myoblasts cells, the same
  extracellular stimuli will activate more JAK2, leading to its phosphorylation. Phosphorylated
  JAK2 can activate PI3K and Ras but without STAT3, resulting in activation of the
  AKT and ERK1/2 signaling pathway, which further activates mTOR and promotes Bcl-2,
  Bcl-XL and CREB up-regulation and caspase 9 down-regulation, contributing to inhibition
  of autophagy and apoptosis and thus making JAK2 perform an important protective
  role in I/R injury. (Bad: Bcl-xL/Bcl-2-associated death promoter; CREB: cAMP regulatory-binding
  protein; Bcl-2: B-cell lymphoma-2; Bcl-XL: B-cell lymphoma-extra large).'
papertitle: Muscular proteomic profiling of deep pressure ulcers reveals myoprotective
  role of JAK2 in ischemia and reperfusion injury.
reftext: Zan Liu, et al. Am J Transl Res. 2018;10(11):3413-3429.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9545728
figid_alias: PMC6291713__F8
figtype: Figure
redirect_from: /figures/PMC6291713__F8
ndex: 084d995b-deed-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6291713__ajtr0010-3413-f8.html
  '@type': Dataset
  description: 'JAK2 overexpression alleviates C2C12 myoblasts I/R injury through
    the AKT and ERK1/2 pathway. As JAK2 is overexpressed in C2C12 myoblasts cells,
    the same extracellular stimuli will activate more JAK2, leading to its phosphorylation.
    Phosphorylated JAK2 can activate PI3K and Ras but without STAT3, resulting in
    activation of the AKT and ERK1/2 signaling pathway, which further activates mTOR
    and promotes Bcl-2, Bcl-XL and CREB up-regulation and caspase 9 down-regulation,
    contributing to inhibition of autophagy and apoptosis and thus making JAK2 perform
    an important protective role in I/R injury. (Bad: Bcl-xL/Bcl-2-associated death
    promoter; CREB: cAMP regulatory-binding protein; Bcl-2: B-cell lymphoma-2; Bcl-XL:
    B-cell lymphoma-extra large).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Oamb
  - csw
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - Pak
  - mbt
  - rl
  - cass
  - Debcl
  - Mtor
  - Tor
  - Atg6
  - Dronc
  - CrebB
  - CrebA
  - Is
  - thi
  - thiv
  - shop
  - cn
  - be
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Dsor1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - IFNG
  - TYK2
  - JAK2
  - PTPN11
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - AKT2
  - AKT3
  - STAT3
  - PAK1
  - PAK2
  - PAK3
  - PAK4
  - PAK5
  - PAK6
  - MAPK3
  - MAPK1
  - BAD
  - BCL2
  - MTOR
  - BECN1
  - CTSA
  - CTSB
  - CTSC
  - CTSD
  - CTSE
  - CTSF
  - CTSG
  - CTSH
  - CTSK
  - CTSL
  - CTSO
  - CTSS
  - CTSV
  - CTSW
  - CTSZ
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - ZAN
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MAP2K1
  - MAP2K2
  - DHormones
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
